Bioscience Biotechnology Research Communications

An Open Access International Journal

P-ISSN: 0974-6455 E-ISSN: 2321-4007

Bioscience Biotechnology Research Communications

An Open Access International Journal

Heenu Dhar and Poonam Salwan

Department of Pharmacology Shree Guru Gobind Singh
Tricentary University, Gurugram, Haryana, India

Corresponding author email: heenu_fmhs@sgtuniversity.org

Article Publishing History

Received: 09/05/2021

Accepted After Revision: 18/07/2021

ABSTRACT:

COVID-19 or SARS CoV2 have caused a devastation situation in the world. People are dying at a rapid rate while scientists and researchers are facing problems in designing a virus against this disease. Many FDA approved drugs have been prescribed but they are not that effective. There is an urgent need for a vaccine with no side effects to cure this disease permanently. Nature had a hidden treasure of medicinal plants that can help the humans in eradicating this disease, one of them is Luteolin. It has shown anti-inflammatory, anti-cancer properties and have been previously used against other homologous strains of the virus existing previously. It is our hope to design a proper vaccine or drug against to overcome this pandemic situation. The current research is based on the in-silico studies of Luteolin and SARS CoV2 main protease to display potential of Luteolin as potential therapy against COVID-19. The results of present study form a basis of further experiments to examine Luteolin as antiviral compound.

KEYWORDS:

Atomic Contact Energy (ACE), COVID-19, Global Energy, Flavanoid, Luteolin, SARS CoV2 MPro.

Download this article as:

Copy the following to cite this article:


Copy the following to cite this URL: